Peak Sales Potential of Merck's (MRK) Keytruda is Underappreciated - Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. DKS
2. INTU
3. ZM
4. SMTC
5. META
6. SPY
7. NCNO
8. JAZZ
9. NVDA
10. BOX

Go back to Peak Sales Potential of Merck's (MRK) Keytruda is Underappreciated - Analyst
Merck & Co. (NYSE: MRK) Delayed: 153.65 -2.8 (1.79%)
Previous Close $156.45    52 Week High $65.46 
Open $154.35    52 Week Low $47.97 
Day High $155.19    P/E 104.52 
Day Low $153.00    EPS $1.47 
Volume 3,369,916